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Background: Idiopathic normal pressure hydrocephalus (iNPH) is one of few types of dementia that can be treated
with shunt surgery and cerebrospinal fluid (CSF) diversion. It is frequently present with cerebral vasculopathy;
however, how the prevalence of cardiovascular disease compares between iNPH patients and the general
population has not yet been established. Therefore, a case–control study was performed to examine whether the
prevalence of cardiovascular disease (arterial hypertension, angina pectoris, cardiac infarction, and diabetes) was
different in 440 iNPH patients, when compared to 43,387 participants of the Nord-Trøndelag Health 3 Survey (The
HUNT3 Survey), which was considered as the general control population.
Findings: In iNPH patients aged 35–70 years, we found increased prevalence for arterial hypertension (males),
angina pectoris (females and males), and cardiac infarction (males), as compared with the HUNT3 control group
with significant odds ratio estimates. In addition, the prevalence of diabetes was increased in both age groups
35–70 years (males) and 70–90 years (females and males).
Conclusions: The data show significantly increased prevalence of cardiovascular disease iNPH patients, which
provide evidence that cardiovascular disease is involved as an exposure in the development of iNPH.
Keywords: Idiopathic normal pressure hydrocephalus, Cardiovascular disease, The HUNT3 Survey, General
population, Arterial hypertension, Angina pectoris, Cardiac infarction, DiabetesFindings
Introduction
The clinical entity idiopathic normal pressure hydroceph-
alus (iNPH) is characterized by dementia, gait ataxia, urin-
ary incontinence and enlarged cerebral ventricles [1]. Even
though the disease was described about 50 years ago [2],
its cause remains unknown.
Several lines of evidence suggest an association between
cardiovascular disease as an exposure and risk factor in
the development of iNPH [3-8]. However, the studies have
included a small number of patients and hospital-based
control groups. Thus, it was recently pointed out that* Correspondence: p.k.eide@medisin.uio.no
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unless otherwise stated.further studies are needed to clarify the association be-
tween iNPH and cardiovascular risk factors, preferably in-
cluding population-based controls [9].
This study was undertaken to examine whether the oc-
currence of cardiovascular disease in iNPH patients is
higher than in the general population. In Norway a popu-
lation based public health study, The Nord-Trøndelag
Health Study (HUNT), has run since 1984. More than
50,000 individuals participated in The HUNT3 (2006–
2008) survey. We compared the occurrence of cardio-
vascular disease in iNPH patients managed within our
department 2002–2011 with the HUNT3 cohort.Materials and methods
The study was approved by The Regional Committee for
Medical and Health Research Ethics (REK) of Healthal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Demographic data of iNPH cases/HUNT-3 cohort
aged 35–90 years
iNPH HUNT3 p-value
N 440 43,387
Gender (F/M) 220/220 23,372/20,015 NS
Mean age (±std) 70.7 ± 9.8 57.3 ± 12.9 <0.001
Arterial hypertension (N/%) 184 (41.8%) 10,441 (24.1%) <0.001
Angina pectoris (N/%) 49 (11.1%) 1,769 (4.1%) <0.001
Cardiac infarction (N/%) 41 (9.3%) 1,625 (3.7%) <0.001
Diabetes mellitus II (N/%) 69 (15.7%) 2,180 (5.0%) <0.001
Height (cm) 171.4 ± 8.9 170.3 ± 9.2 NS
Weight (kg) 76.4 ± 15.5 79.8 ± 15.0 <0.001
BMI (kg/m2) 26.0 ± 4.6 27.4 ± 4.3 <0.001
iNPH = idiopathic normal pressure hydrocephalus; 4HUNT3 = The HUNT3
Survey. NS = non-significant.
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University Hospital (2011/6692), Oslo, Norway. A case–
control study design was used.
iNPH patients
The patient material included patients managed for
probable or possible iNPH within the Department of
Neurosurgery, Oslo University Hospital, Rikshospitalet,
during 10-year period 2002 to 2011. The diagnosis of
iNPH was based on clinical neurological examination,
radiological assessment of ventricular size using com-
puted tomography (CT) or MRI. Normal intracranial
pressure (ICP) was documented by over-night ICP mon-
itoring. The clinical neurological examination revealed
2–3 of the triad of gait ataxia, urinary incontinence and
dementia, increased ventricular size revealed by CT or
MRI. The diagnostic criteria of probable and possible
iNPH has been described previously [10]. It was beyond
the scope of this study to differentiate the probable and
possible iNPH sub-groups.
Population based HUNT3 cohort
Data from The HUNT3 Survey was used as an estimate
of the control population. During the period 2006–2008,
all inhabitants in the county of Nord-Trøndelag, Norway,
aged 20 years and older were invited to participate in a
general health study, named Nord-Trøndelag Health Study
3 (The HUNT3 Survey; http://www.ntnu.no/hunt). This
study included physical examinations, blood samples and
questionnaires that covered demographic characteristics,
somatic illnesses, somatic and mental symptoms, medica-
tions, lifestyle and health-related behavior. The population
of Nord-Trøndelag County is stable and homogenous with
less than 3% non-Caucasians, and is representative for
Norway in general, though not containing any large cities.
The presence of cardiovascular disease as a risk factor
This was defined in the same way in the iNPH and
HUNT3 cohorts. For the iNPH patients (i.e. cases), it
was either reported by the referring doctor/neurologist,
and/or by the patient or his/her relatives. For the par-
ticipants in The HUNT3 Survey (i.e. controls), it was
based on self-reported cardiovascular disease in a stan-
dardized questionnaire. The patients/relatives answered
the following questions:
– Do you take or have you taken medication for high
blood pressure?
– Have you had or do you have any of the following:
angina pectoris (chest pain)?
– Have you had or do you have any of the following:
myocardial infarction (heart attack)?
– Have you had or do you have any of the following:
diabetes?Data analysis
Descriptive statistics are mean (standard deviation) or
number of patients (percentage) and difference between
groups assessed with student t-test or chi-square tests
for crosstabs if not otherwise stated. Exposure odds
ratios (OR) with 95% confidence intervals (95CI) and
p-values for the cardiovascular diseases were calcu-
lated. To take into account both the confounding and
modifying effects of age and sex, a stratified analysis
on both sex and age at a cut-off of 70 years, was con-
ducted. The odds ratios for the resulting four stratified
groups are presented. Effect of residual differences in
age distribution between cases and controls within
these stratified groups were adjusted for using logistic
regression by including age as a continuous independ-
ent variable. BMI as exposure was examined as a con-
tinuous variable and the resulting odds ratio assessed
with binary logistic regression. Statistical significance
was accepted at the 0.05 level. All statistical analysis
was performed using the SPSS software version 20
(IBM Corporation, Armonk, NY).
Results
Table 1 presents demographic data of the 440 iNPH pa-
tients and the 43,387 individuals of the HUNT3 cohort,
35–90 years of age. The subjects were stratified into those
aged 35–70 years and 70–90 years, analyzed separately for
female and male subjects, and adjusted for age. For the
35–70 years group, the mean age was 61 and 53 years for
iNPH and HUNT3 cohorts, respectively, while mean age
was 77 years for both iNPH and HUNT3 cohorts of the
70–90 years age groups.
Tables 2, 3, 4 and 5 present the prevalence of arter-
ial hypertension, angina pectoris, cardiac infarction,
and diabetes. With reference to the age-adjusted ORs
(Tables 2, 3, 4 and 5, right column), the iNPH patients
35–70 years of age presented with significantly increased
Table 2 Prevalence of arterial hypertension according to gender and age-group in iNPH cases/HUNT3 cohort
Arterial hypertension Crude estimate Age-adjusted estimate
Age (years) Gender Total Yes No OR (95% CI), p-value OR (95% CI), p-value
iNPH ≥ 35 - 70 Female 95 32 (33.7%) 63 (66.3%) 2.4 (1.5 – 3.6), <0.001 1.4 (0.9 – 2.1), NS
HUNT3 ≥ 35 - 70 Female 18,988 3,353 (17.7%) 15,635 (82.3%)
iNPH ≥ 35 - 70 Male 81 40 (49.4%) 41 (50.6%) 4.1 (2.7 – 6.4), <0.001 2.2 (1.4 – 3.5), <0.001
HUNT3 ≥ 35 - 70 Male 16,425 3,140 (19.1%) 13,285 (80.9%)
iNPH ≥70 - 90 Female 125 58 (46.4%) 67 (53.6%) 0.8 (0.6 – 1.2), NS 0.9 (0.6 – 1.2), NS
HUNT3 ≥70 - 90 Female 4,384 2,215 (50.5%) 2,169 (49.5%)
iNPH ≥70 - 90 Male 139 54 (38.8%) 85 (61.2%) 0.7 (0.5 – 1.0), 0.030 0.7 (0.5 – 1.0), 0.030
HUNT3 ≥70 - 90 Male 3,590 1,733 (48.3%) 1,857 (51.7%)
iNPH = idiopathic normal pressure hydrocephalus; 4HUNT3 = The HUNT3 Survey; OR = odds ratio; CI = confidence interval. Data presented as numbers
(percentages in parenthesis). NS = non-significant.
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angina pectoris (females and males; Table 3), cardiac
infarction (males; Table 4). The prevalence of diabetes
was increased in both age groups 35–70 years (males)
and 70–90 years (females and males; Table 5).
In the group of 440 iNPH patients, 289 were manged
with shunt surgery while 151 were managed conserva-
tively. Notably, the ORs for arterial hypertension, angina
pectoris, cardiac infarction and diabetes were comparable
between iNPH patients in the surgery group (n = 289) and
the total cohort (n = 440; data not shown).
Discussion
The main observation here is that the prevalence of ar-
terial hypertension, angina pectoris, cardiac infarction
and diabetes was significantly increased in iNPH patients
as compared with the general population, represented by
the HUNT3 cohort.
O’Connell was the first to suggest that cerebrovascular
disease and white matter lesions could result in hydro-
cephalus [11]. Since iNPH was described in 1965, only a
few studies incorporating a rather small number of pa-
tients have explored the occurrence of cardiovascular
disease in iNPH. Hence, arterial hypertension was seenTable 3 Prevalence of angina pectoris according to gender an
Angina pe
Age (years) Gender Total Yes
iNPH ≥ 35 - 70 Female 95 6 (6.3%)
HUNT3 ≥ 35 - 70 Female 18,988 212 (1.1%)
iNPH ≥ 35 - 70 Male 81 10 (12.3%)
HUNT3 ≥ 35 - 70 Male 16,425 514 (3.1%)
iNPH ≥70 - 90 Female 125 10 (8.0%)
HUNT3 ≥70 - 90 Female 4,384 468 (10.7%)
iNPH ≥70 - 90 Male 139 23 (16.5%)
HUNT3 ≥70 - 90 Male 3,590 575 (16.0%)
iNPH = idiopathic normal pressure hydrocephalus; 4HUNT3 = The HUNT3 Survey; OR
(percentages in parenthesis). NS = non-significant.in 14 of 19 (74%) iNPH patients while in 38 of 142
(27%) control subjects [7]. In another study, arterial
hypertension, diabetes, and ischemic heart disease was
more frequent in a group of 17 iNPH patients than in
51 control subjects [8]. Furthermore, Krauss et al. [6]
reported arterial hypertension in 54/65 (83%) iNPH pa-
tients but only in 25/70 (36%) control subjects. Regard-
ing diabetes, one study reported diabetes in 17/33 (52%)
iNPH cases, as compared to 4/33 (12%) age-matched
controls [12]. While the studies referred to used small
hospital-based control groups, the present study is the
first study to compare cardiovascular disease against a
general population-based cohort in iNPH patients.
The need for population-based studies relates to the
fact that the occurrence of cardiovascular disease highly
depends on age, race, gender and geographic location. For
example, regarding arterial hypertension, Wolf-Maier
et al. [13] showed the great variance of the prevalence
of arterial hypertension between and within continents.
While about 28% of the population in North-America
had high blood pressure (>140/90), the prevalence of
arterial hypertension in Europe was overall 44%. Great
variation was even seen within Europe; Germany had
the highest frequency (55%) and Italy the lowest (38%).d age-group in iNPH cases/HUNT3 cohort
ctoris Crude estimate Age-adjusted estimate
No OR (95% CI), p-value OR (95% CI), p-value
89 (93.7%) 6.0 (2.6 – 13.8), <0.001 3.3 (1.4 – 7.7), 0.006
18,776 (98.9%)
71 (87.7%) 4.4 (2.4 – 8.5), <0.001 2.2 (1.1 – 4.3), 0.023
15,911 (96.9%)
115 (92.0%) 0.7 (0.4 – 1.4), NS 0.7 (0.4 – 1.4), NS
3,916 (89.3%)
116 (83.5%) 1.0 (0.7 – 1.6), NS 1.0 (0.7 – 1.6), NS
3,015 (84.0%)
= odds ratio; CI = confidence interval. Data presented as numbers
Table 4 Prevalence of cardiac infarction according to gender and age-group in iNPH cases/HUNT3 cohort
Cardiac infarction Crude estimate Age-adjusted estimate
Age (years) Gender Total Yes No OR (95% CI), p-value OR (95% CI), p-value
iNPH ≥ 35 - 70 Female 95 2 (2.1%) 93 (97.9%) 2.8 (0.7 – 11.6), NS 1.5 (0.4 – 6.4), NS
HUNT3 ≥ 35 - 70 Female 18,988 143 (0.8%) 18,845 (99.2%)
iNPH ≥ 35 - 70 Male 81 13 (16.0%) 68 (84.0%) 5.0 (2.8 – 9.1), <0.001 2.6 (1.4 – 4.7), 0.002
HUNT3 ≥ 35 - 70 Male 16,425 604 (3.7%) 15,821 (96.3%)
iNPH ≥70 - 90 Female 125 7 (5.6%) 118 (94.4%) 0.8 (0.64 – 1.8), .NS 0.8 (0.4 – 1.8), NS
HUNT3 ≥70 - 90 Female 4,384 298 (6.8%) 4,086 (93.2%)
iNPH ≥70 - 90 Male 139 19 (13.7%) 120 (86.3%) 0.8 (0.5 – 1.3), NS 0.8 (0.5 – 1.3), NS
HUNT3 ≥70 - 90 Male 3,590 580 (16.2%) 3,010 (83.8%)
INPH = idiopathic normal pressure hydrocephalus; 4HUNT3 = The HUNT3 Survey; OR = odds ratio; CI = confidence interval. Data presented as numbers
(percentages in parenthesis). NS = non-significant.
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study (The HUNT3 Survey) for the comparison of the
prevalence of cardiovascular disease. Hence, our control
population is the same as the source population for the
iNPH patient cohort.
The diagnosis of iNPH is not very well defined. Thus,
a major issue has been to precisely define which patients
that will respond to shunting, which is the only effective
treatment [14]. With regard to determining the pre-
valence of cardiovascular disease in iNPH, the lack of
strict diagnostic criteria represents a challenge. Re-
cently, a classification of iNPH differentiated between
probable, possible and unlikely iNPH [10]. Since, the
present patients included probable or possible iNPH,
we consider the present patient cohort to be a repre-
sentative cohort of iNPH patients. Moreover, we com-
pared the occurrence of cardiovascular disease and
ORs between the total cohort of 440 iNPH patients
and those 289 undergoing shunt surgery and found
comparable results.
The method used for diagnosing cardiovascular dis-
ease can be discussed. One obvious limitation is that the
presence of disease is self-reported. Particularly in iNPH
patients with variable degree of cognitive failure, thisTable 5 Prevalence of diabetes according to gender and age-
Diabe
Age (years) Gender Total Yes
iNPH ≥ 35 - 70 Female 95 6 (6.3%)
HUNT3 ≥ 35 - 70 Female 18,988 635 (3.3%)
iNPH ≥ 35 - 70 Male 81 20 (24.7%)
HUNT3 ≥ 35 - 70 Male 16,425 769 (4.7%)
iNPH ≥70 - 90 Female 125 21 (16.8%)
HUNT3 ≥70 - 90 Female 4,384 413 (9.4%)
iNPH ≥70 - 90 Male 139 22 (15.8%)
HUNT3 ≥70 - 90 Male 3,590 363 (10.1%)
INPH = idiopathic normal pressure hydrocephalus; 4HUNT3 = The HUNT3 Survey; OR
(percentages in parenthesis). NS = non-significant.may lead to under-reporting of occurrence of cardio-
vascular disease, even though relatives answered as
well. In the present study cohort, the prevalence of car-
diovascular disease was particularly increased in males,
and individuals aged 35–70 years. However, the preva-
lence of angina pectoris and diabetes was also increased
in females and for diabetes in the age group 70–90
years. Accordingly, cardiovascular disease as an expos-
ure seems to affect both genders and all age groups
from 35–90 years.
It is presently not clear how vascular pathology such
as atherosclerosis affect CSF homeostasis. The cerebral
water compartments are closely linked to the cerebro-
vascular system [15]. Recently the importance of para-
vascular water exchange in the brain was described
[16,17]. Hence, further studies are needed to understand
how vascular pathology affects cerebral water exchange.Conclusions
The data show significantly increased prevalence of
cardiovascular disease in iNPH patients, which provide
evidence that cardiovascular disease is involved as an
exposure in the development of iNPH.group in iNPH cases/HUNT3 cohort
tes Crude estimate Age-adjusted estimate
No OR (95% CI), p-value OR (95% CI), p-value
89 (93.7%) 2.0 (0.9 – 4.5), NS 1.3 (0.6 – 2.9), NS
18,353 (96.7%)
61 (75.3%) 6.7 (4.0 – 11.2), <0.001 4.0 (2.4 – 6.8), <0.001
15,656 (95.3%)
104 (83.2%) 2.0 (1.2 – 3.1), 0.007 2.0 (1.2 – 3.2), 0.006
3,971 (90.6%)
117 (84.2%) 1.7 (1.1 – 2.7), .031 1.7 (1.1 – 2.7), .031
3,227 (89.9%)
= odds ratio; CI = confidence interval. Data presented as numbers
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